Apply on Employer Site

Arvinas · 1 day ago

Co-op Biology-Oncology

New Haven, CT

Internship

Onsite

Intern

Start in 2026 Spring

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. The Spring 2026 Oncology Biology Co-Op position focuses on evaluating novel degrader molecules on oncology targets and validating new targets for potential degrader discovery efforts in a collaborative laboratory environment.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Growth Opportunities

No H1B

Responsibilities

Cell culture including sterile technique for mammalian cell lines

Functional genomics approaches (such as CRISPR KO, siRNA/shRNA KD) to interrogate targets to understand their biological function, especially at scale or in a hypothesis-driven way

Cellular assays to monitor activity of degrader compounds (such as Western blot, JESS, high-content imaging, HiBiT, NanoBRET)

Establishing and developing new assays to detect target engagement and small molecule binding to targets in vitro and in cells

Data analysis and interpretation, as well as presenting data in team meetings

Meeting with key stakeholders outside of the project team to devise future experiments for downstream applications

Qualification

Cell cultureImmunoblottingGenetic perturbation assaysOncology experienceComputational analysisFast learnerMulti-taskingData analysisTeam collaboration

Required

The candidate should be a highly motivated fast learner with flexibility and ability to multi-task, as well as a good lab citizen

Experience in cell culture is required

Experience with immunoblotting and genetic perturbation assay skills are required

Ability to work full-time (40 hours per week)

Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for a current or future VISA sponsorship

The duties of this role are generally conducted in a lab environment. Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortable in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours

Preferred

Prior lab experience highly preferred

Previous oncology experience is preferred

Knowledge of ubiquitin-based proteasomal degradation is desired, but not a pre-requisite

Experience in the computational analysis and interpretation of omics datasets, such as RNA-seq and proteomics, to inform biological hypotheses, target identification, and mechanistic understanding is considered a plus

Preference to Master's / PhD student currently enrolled in a program with a concentration in cell biology, immunology, pharmacology, biology, or related fields